In an Initial Decision announced today, Chief Administrative Law Judge D. Michael Chappell upheld a Federal Trade Commission complaint challenging the consummated merger of two prosthetics manufacturers that are top sellers of prosthetic knees equipped with microprocessors.
What:The Federal Trade Commission will host the 13th session of its Hearings on Competition and Consumer Protection in the 21st Century.When:Friday, April 12, 9:00 a.m. - 5:15 p.m.Where:FTC Headquarters
Tronox Limited and Cristal, two of the largest suppliers of the white pigment chloride process titanium dioxide, have agreed to settle Federal Trade Commission charges by divesting Cristal’s North American titanium dioxide assets, thereby preserving competition in the market for this important and...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Fresenius Medical Care AG’s proposed $2 billion acquisition of NxStage Medical, Inc. likely would be anticompetitive.
Designing effective merger remedy orders is one of the Commission’s most important tasks. An effective merger remedy prevents the merger from causing harm.